Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

VEINAMINE 8%

AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE

Standard Dose
8%;61MG/100ML;211MG/100ML;56MG/100ML;388MG/100ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview VEINAMINE 8% is listed in Drugs@FDA under application 017957 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE Form and strength INJECTABLE;INJECTION - 8%;61MG/100ML;211MG/100ML;56MG/100ML;388MG/100ML Sponsor HOSPIRA INC Submission history Latest submission status date: 2005-01-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview VEINAMINE 8% is listed in Drugs@FDA under application 017957 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE Form and strength INJECTABLE;INJECTION - 8%;61MG/100ML;211MG/100ML;56MG/100ML;388MG/100ML Sponsor HOSPIRA INC Submission history Latest submission status date: 2005-01-12 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.